Home Latest Articles
Latest Articles
  • Fujia XIE, Zhijie FANG, Zhihui ZHOU, Lingling FENG, Jun LU
    Chinese Journal of Pharmaceuticals. 2023, 54(8): 1182-1186.

    In this study, an improved refining process of tofacitinib citrate was reported, and the critical related substances were analyzed and controlled. Tofacitinib was purified in the acetonitrile-water mixed solvent, and the purity of the product was greater than 99.0%. Tofacitinib citrate was recrystallized in water, and the product purity was greater than 99.9%, with maximum single impurity less than 0.05%. The critical related substances of K, U, V and R(detected in the crude product and reference preparation) were synthesized, and their structures were confirmed by 1H NMR,13C NMR and ESI-MS.

  • Mingming DONG, Jiawei TANG, Shaoxin CHEN, Fuli ZHANG, Jianbo WANG, Jun YU
    Chinese Journal of Pharmaceuticals. 2023, 54(8): 1187-1192.

    In this paper, the synthesis process of a key chrial intermediate of nirmatrelvir, named methyl(1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylate(1) hydrochloride was improved. Compound 6,6-dimethyl-3-oxobicyclo[3.1.0]hexane-2,4-dione(2) was used as the starting material to synthesize 6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2,4-dione(9) by ammoniation with urea. Compound 6,6-dimethyl-3-azabicyclo[3.1.0]-hexane(5) was synthesized from 9 by reduction. Compound (1R,5S)-6,6-dimethyl-3-azabicyclo[3.1.0]hexene(6) was stereoselectively synthesized from 5 via oxidation by the engineered bacteria containing monoamine oxidase AtMAON-M12. Compound 1 hydrochloride was obtained from 6 with purity of 99.9% and enantiomeric excess up to 99.9% by addition, cyanidation, Pinner reaction and salification, while the total yield reached 60.5%. The single enantiomer 6 was obtained by using monoamine oxidase AtMAON-M12 without resolution, which conformed to the green chemistry principle of atom economy.

  • Ruosong QIN, Guorong XIAO, Liandi ZHANG
    Chinese Journal of Pharmaceuticals. 2023, 54(8): 1193-1197.

    Benzyl (2R,4S)-5-oxo-2,4-diphenyloxazolidine-3-carboxylate(3) was obtained from N-carbobenzoxy-L-phenylglycine(2) by substitution with benzadehyde dimethyl acetal. In this reaction, acetonitrile was used as the reaction solvent instead of di-isopropyl ether in the original literature, which greatly simplified the operation and shortened the reaction time. Benzyl (2R,4S)-4-[[(R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]methyl]-5-hydroxy-2,4-diphenyloxazolidine-3-carboxylate(5) was generated by substitution and reduction of compound 3. Compound 5, without hydrolysis, reacted directly with methyl bromide triphenylphosphine salt(Ylide reagent) in the"one pot" Wittig reaction to generate benzyl [(S)-1-[(R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-2-phenylbut-3-en-2-yl]carbamate(7). This reaction increased the yield from 54% to 90%, and shorted the reaction time from 24 h to 6 h. After amino deprotection and salt production, the key intermediate of rolapitant, (S)-1-[(R)-1-[3,5-bis(trifluoromethyl)-phenyl]ethoxy]-2-phenylbutyl-3-en-2-amine maleate(1) was obtained with the overall yield of 59% and the purity of 99.8%. The improved process was more suitable for industrial application.

  • Kesheng ZHANG, Huantian GE, Bin SUN, Can JIN
    Chinese Journal of Pharmaceuticals. 2023, 54(8): 1198-1201.

    An improved synthetic process of 1α-hydroxycholesterol(1), a key intermediate of 1α-hydroxyvitamin D3, was reported by using cholesterol as raw material(2) through five steps, including oxidative dehydrogenation, epoxidation, selective ring opening, isomerization and reduction. Compared with the existed preparation process of 1, on the one hand, this route featured simple operation and mild conditions, avoiding the harsh conditions of liquid ammonia/lithium reduction at -78 ℃. On the other hand, the ring-opening of 1α,2α-epoxy-4,6-cholestadiene-3-one(4) was carried out by using phenylselenol, and the isomerization of ketene to enol ester was achieved by I2/isopropylacetate system. After the optimization, the total yield for synthesis of 1 was 40% with purity of 98%.

  • Hao QIU, Shoushuai QIU, Yiwen WANG, Ranzhang CHEN, Qingfang CHENG
    Chinese Journal of Pharmaceuticals. 2023, 54(8): 1202-1207.

    In order to control the quality of rosuvastatin calcium, five related substances of rosuvastatin calcium were synthesized: [(3R,5S, E)-7-[4-(4-fluorophenyl)-2-[[2-[4-(4-fluorophenyl)-6-isopropyl-2-[N-methyl(methanesulfonamido)]pyrimidin-5-yl]-2-hydroxyethyl]-N-methylsulfonamido]-6-isopropylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate] calcium salt(related substance A), [(3R,5S, E)-7-[4-(4-fluorophenyl)-2-[[(E)-2-[4-(4-fluorophenyl)-6-isopropyl-2-[N-methyl(methanesulfonamido)]pyrimidine-5-yl]vinyl]-N-methylsulfonamide]-6-isopropylpyrimidin-5-yl]-3,5-dihydroxyheptyl-6-enoate] calcium salt(related substance B), N-[4-(4-fluorophenyl)-5-[(E)-2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]vinyl]-6-isopropylpyrimidin-2-yl]-N-methylmethanesulfonamide(related substance C), N-[(R)-8-fluoro-6-[(2S,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]-4-isopropyl-5,6-dihydrobenzo[h]quinazolin-2-yl]-N-methylmethanesulfonamide(related substance D), and N-[(S)-8-fluoro-6-[(2S,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]-4-isopropyl-5,6-dihydrobenzo[h]quinazolin-2-yl]-N-methylmethanesulfonamide(related substance E). And their structures were confirmed by MS, 1H NMR and the optical rotation.

  • Conghui LI, Zhenxin LI, Zhengyu ZHANG, Songbai YANG, Dong YI, Shaoxin CHEN
    Chinese Journal of Pharmaceuticals. 2023, 54(8): 1208-1215.

    Polymyxin B(1), a basic polypeptide antibacterial drug, was mainly produced by Paenibacillus polymyxa and showed significant effects on treatment of drug-resistant bacterial infections. The main components of 1 include B1, B2, B3, and B1-I. To increase the yield of 1, this study with P. polymyxa SIPI PB-1[fermentation unit:(837±50)mg/L] as the starting strain, obtained the mutant strain SIPI PB-N14[fermentation unit:(1 297±60)mg/L]through traditional mutagenesis and selection. Then, the fermentation medium and fermentation process of SIPI PB-N14 were optimized. Under the optimized fermentation conditions, the fermentation yield of 1 in a 5 L fermenter could reach(1 681±25)mg/L, of which the proportions of B1, B2, B3, and B1-I were (74.5±1.1)%, (20.4±0.8)%, (1.3±0.3)%, and(3.0±0.1)%, which met the requirements of API components and provided test data for industrial production.

  • Hongjuan SHI, Xu OUYANG, Ruiqiang WANG, Zhongyan WANG
    Chinese Journal of Pharmaceuticals. 2023, 54(8): 1216-1223.

    This study developed the formulation and preparation of azithromycin(1) dry suspension based on the concept of quality by design(QbD). First, 1 and trisodium phosphate were granulated to improve the taste, then 1 particles and sucrose(grinding) were granulated, followed by mixing with the added sucrose. The second-step granulation and mixing process were optimized by Box-Behnken design with granulation time, adding sucrose ratio after granulation, and mixing time as independent variables and content uniformity as the dependent variable. The optimal process was as follows: granule time was 14 min, adding sucrose ratio was 40%, and mixing time was 44 min. Three batches of process validation samples prepared according to the optimized parameters had an average content uniformity of 2.3. And the dissolution behaviors of self-made preparations(T) and reference preparations(R) were similar in media with pH values of 2.0, 4.5, and 6.0. The bioequivalence between T and R was studied through a three-cycle partially repeated cross-over design in healthy volunteers. The results showed that under fasting conditions, the cmax of T and R were 114.675 and 114.917 ng/mL, the AUC0→t were 552.41 and 594.87 h·ng·mL–1; under fed conditons, the cmax of T and R were 37.755 and 32.945 ng/mL, the AUC0→t were 276.66 and 257.87 h·ng·mL–1. The statistical analysis results of reference-scaled average bioequivalence(RSABE) or average bioequivalence(ABE) showed that T and R were bioequivalent. The quality and efficacy of the 1 dry suspension prepared in this study were consistent with the reference.

  • Jungang REN, Ke XU
    Chinese Journal of Pharmaceuticals. 2023, 54(8): 1224-1232.

    In this study, borneol-modified carbamazepine(1) nanoparticles were prepared by solvent diffusion method using PLGA as carrier material, and their tissue distribution in mice was investigated. First, the formulation was optimized by Box-Behnken design combined with response surface methodology with poloxamer 188 concentration, PLGA amount, the volume ratio of oil-to-water, and mass ratio of drug-to-lipid as the independent variables, and the entrapment efficiency and particle size as the dependent variables. The in vitro characterization results showed that the average particle size of the borneol-modified 1 nanoparticles prepared by the optimized formnlation was 90 – 100 nm, the entrapment efficiency and drug loading were about 72% and 6.7%. After tail intravenous administration of the self-made borneol-modified 1 nanoparticles to mice, the distribution behavior, especially the brain targeting of 1 in mice was investigated. The results showed that borneol-modified 1 nanoparticles could significantly extend the average residence time in mice, and borneol could promote the transport of 1 nanoparticles across the blood-brain barrier. The results indicated that the borneol-modified 1 nanoparticles had the potential to treat epilepsy.

  • Yuhong LIU, Yu JIANG, Guizhou HAO, Shankui LIU
    Chinese Journal of Pharmaceuticals. 2023, 54(8): 1233-1240.

    In order to improve storage stability and reduce residual ethanol, cabazitaxel nanoliposomes were prepared into lyophilized injection, and the lyophilization process was investigated and optimized. Taking the appearance, main drug content, encapsulation efficiency, moisture content, residual ethanol and the storage stability of lyophilized powder as evaluation indicators, the effects of dosage of lyophilized protective agent(sucrose), the filling volume of feed liquid, pre-freezing speed and drying temperature on the quality of the lyophilized injection were investigated. The results showed that the optimum mass ratio of sucrose to phospholipid was 5.0; the mass concentration of cabazitaxel in the nanoliposomes was 2 mg/mL; specification was 20 mg per bottle; xilin bottle specification was 20 or 30 mL. The optimal lyophilization process parameters were as follows: the pre-freezing temperature was –40 ℃, the shelf cooling time was 90 min, then holding at –40 ℃ for 5 h; the primary drying was conducted at –15 ℃ for 14 h; the secondary drying was conducted at 28 ℃ for 28 h; the total lyophilization time was 48.83 h; a stepwise heating mode was adopted in the whole drying process. The lyophilization cycle of optimal process was greatly shortened, and the obtained lyophilized injection had good storage stability.

  • Taomin LI, Banggui PENG, Lanlan ZHANG, Rongrong HE, Liaoyuan LIU
    Chinese Journal of Pharmaceuticals. 2023, 54(8): 1241-1246.

    A three-factor and three-level experiment was conducted with decoction time, adding amount of water and decocting times as the independent variables by Box-Behnken design combined with response surface methodology. The weights for evaluating indexes, namely the extraction yield and the contents of narirutin, hesperidin, nobiletin and tangeretin were calculated by analytic hierarchy process(AHP), entropy weight method and the combination of AHP and entropy weight method, respectively. Then, the comprehensive score of the above 5 indicators was used as the evaluation index to optimize the extraction process parameters of tangerine peel formula granules. The results showed that the optimized extraction process parameters were as follows: adding 14 times of the amount of water, decocting 3 times, and 60 min per extraction. The results of verification test showed that the extraction process was stable, simple and feasible, which could provide a reference for the preparation process study of tangerine peel formula granules.

News